FTO and acute myeloid leukemia: To verify the role of FTO in mediating chemotherapy resistance in AML progression, we assessed the effect of FTO-knockdown in NPG mice with two regimens of drug administration: vehicle and Ara-C (100 mg/kg, every two days, intravenous injections).